Is there an Indian medicine for Ceritinib?

Ceritinib/Ceritinib (Ceritinib) is a targeted therapy used to treat certain types of non-small cell lung cancer (NSCLC). It is mainly used to treat ALK (tyrosine kinase) fusion-positive NSCLC patients, which is a specific subtype of lung cancer in which cancer cells contain fusions of the ALK gene and other genes, resulting in ALK kinase being abnormally active and promoting the growth and spread of cancer cells.

Ceritinib/There is currently no officially marketed generic version of Ceritinib. CurrentlyCeritinib/Ceritinib has been launched in China and has been included in medical insurance, and patients can purchase it domestically. Although Ceritinib/Ceritinib has been included in medical insurance, the price is still very high. The domestic price ranges from 12,600 to 24,000. Different specifications have different prices. Please consult your local pharmacy for details. Foreign original drugs are divided into original drugs and generic drugs. Foreign original drugs are mainly Swiss Novartis original drugs. Specification150mg*150The price is about13,500 yuan. Generic drugs mainly include Bangladeshi version, with specifications of 150mg*30 and the price is around 1,300 yuan. The ingredients of original drugs and generic drugs are basically the same.

For ALKpositive NSCLC patients, ceritinib/ceritinib can be used as the initial treatment option. For patients with ALKfusion-positive NSCLC who have not received any treatment, Ceritinib can be used as a monotherapy to control the growth and spread of the tumor. Clinical trials have shown that in treatment-naïveALKpositiveNSCLCIn patients, Ceritinib/Ceritinib has shown significant efficacy, which can prolong the patient's survival and improve the treatment response rate.

For ALKfusion-positive NSCLC patients who have been treated with other ALK inhibitors and developed resistance, ceritinib/ceritinib is also used as an alternative treatment option. Some patients may develop drug resistance after using other ALK inhibitors for a period of time. At this time, switching to ceritinib /ceritinib may still have a certain therapeutic effect on cancer.